Global Sleeping Aids Market 2015-2020 - Medication, Sleep Laboratories, Mattresses and Pillows and Sleep Apnea Devices - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/pk5x7k/global_sleeping) has announced the addition of the "Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders, Product, by Medication" report to their offering.

The global sleeping aids market accounted for $58,272.5 million during 2014, and it is expected to grow with a CAGR of 6.2% during 2015-2020

The Insomnia sleep disorder segment dominated the global sleeping aids market during 2014 with about 30% share; whereas, among products, the mattresses and pillows accounted for the highest share of 40% in global sleeping aids market during the same year. Sleeping aids market is escalating with high growth rate due to growing aging population.

The growth of aging population has become the major growth driver for the global sleeping aids market, as with aging people experience various health issues, due to which they become more susceptible to sleep disorders. With the changes in lifestyle, the increased consumption of products containing caffeine, alcohol, smoking and tobacco further leads to disrupted sleep, thus leading to the growth of global sleeping aids market.

The sleeping aid products industry has witnessed huge growth in the recent years. The growing acceptance of mattresses and pillows, sleeping aid medications (sleeping pills), sleep laboratories, sleep apnea devices have increased the demand for sleeping aids. The mattresses and pillows market grew with an average annual growth rate of over 6.0% during 2011-2014. The sleep apnea market on the other hand grew with a CAGR of 6.5% during 2011-2014. The emergence of medications has further laid opportunities for the growth of the global sleeping aids market.

The key companies operating in the global sleeping aids market include Merck & Co., Sanofi, Koninklijke Philips N.V, Pfizer Inc., GlaxoSmithKline PLC., SleepMed Inc., Cadwell Laboratories Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, Takeda Pharmaceutical Company Limited, Compumedics Limited, CareFusion Corporation and Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1. Research Scope and Methodology

2. Executive Summary

3. Market Outlook

4. Global Sleeping Aids Market Size and Forecasts (2011 - 2020)

5. Global Sleeping Aids Market Breakdown by Sleep Disorder Type

6. Global Sleeping Aids Market Breakdown by Product

7. Global Sleeping Aids Market Breakdown by Medication Type

8. Global Sleeping Aids Market Breakdown by Geography

9. Competitive Analysis and Market Share

10. Company Profiles

- Cadwell Laboratories, Inc.

- Carefusion Corporation

- Compumedics Limited

- Devilbiss Healthcare Llc

- Glaxosmithkline Plc

- Koninklijke Philips N.V.

- Merck & Co., Inc.

- Natus Medical Incorporated

- Pfizer, Inc.

- Sanofi

- Sleepmed Inc.

- Takeda Pharmaceutical Company Limited

- Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/pk5x7k/global_sleeping

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System, Immune Disorders, Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System, Immune Disorders, Infectious Diseases